DePuy Weighs HDE Costs; FDA Stresses Data Options Over Statutory Limits
This article was originally published in The Gray Sheet
Executive Summary
The Center for Devices & Radiological Health is encouraging greater use of humanitarian device exemptions by inviting manufacturers to submit alternative forms of data to support submissions
You may also be interested in...
Rare Diseases Working Group Should Address CLIA Lab Participation – SACGT
The Rare Diseases Working Group of the HHS Secretary's Advisory Committee on Genetic Testing should look at ways to shift testing for rare diseases from research labs to CLIA-certified clinical labs, the committee concluded
FDA Plugs HDE Program, Shows Flexibility With Population, Cost Criteria
FDA is seeking broader use of the humanitarian device exemption program by encouraging dialogue with manufacturers about HDE requirements for patient population and cost
EU Parliament Stricter Than Council On Medicines And Medical Devices Packaging
The EU Parliament's Environment, Public Health and Food Safety committee takes a compromise position with regards to the Packaging and Packaging Waste Directive. Medicines and medical devices should be exempt, but only until 2035, at which point the European Commission should check whether the development of materials and the recycling process have progressed, and may adjust this exemption accordingly.